Improving Sexual Health for Ovarian Cancer Patients

0

Treatment for ovarian cancer often comes with sexual side effects. Although curing the cancer is the main goal for many patients and their doctors, Sharon Bober, PhD, director of Dana-Farber’s Sexual Health Program, is focused on preserving a patient’s quality of life – including her sexual satisfaction.

Sharon Bober, PhD

Sharon Bober, PhD, is director of the Sexual Health Program in Dana-Farber’s Perini Family Survivors’ Center.

Bober, with co-investigators Alexi Wright, MD, MPH, a medical oncologist in the Gynecologic Oncology Program at the Susan F. Smith Center for Women’s Cancers, and Christopher Recklitis, PhD, MPH, director of research at Dana-Farber’s Perini Family Survivors’ Center, is leading an intervention to address sexual side effects such as pain, discomfort, and loss of libido in women who have been treated for ovarian cancer. Patients – at any point during their treatment – participate in a small-group, half-day workshop to educate them about these issues, while also exploring the psychological impact of changes in sexuality and intimacy.

Alexi Wright, MD, MPH

Alexi Wright, MD, MPH

The program offers relaxation exercises and information to relieve tension and address the mind-body components of intimacy, and includes practical education on how to improve sexual health and manage discomfort. Bober also discusses the negative way women might talk to themselves about changes in sexuality, and provides strategies for combating these thoughts. Patients leave the first-of-its-kind workshop with an action plan and realistic steps for improving their sexual satisfaction, and afterwards receive phone counseling and questionnaires to assess the intervention’s efficacy.

“This intervention is a powerful collaboration between psychosocial and medical oncology,” says Bober, principal investigator, who notes preliminary results have been overwhelmingly positive. “It allows us to address quality of life in a holistic, comprehensive way.”

Bober and her team are also conducting a focus group to assess the feasibility of moving the intervention online and, eventually, expanding to include other types of gynecologic cancer.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber clinicians have been involved in the development of several new agents approved recently for B-cell acu… https://t.co/Oo3SiY79EN
Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.